Calliditas Therapeutics AB (publ)
CLTEF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $563 | $23 | $20,840 | $797,278 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3 | $0 | $272,049 | $222,586 |
| Inventory | $0 | $0 | $0 | $40,164 |
| Other Curr. Assets | $11 | $0 | -$272,024 | $94,436 |
| Total Curr. Assets | $576 | $23 | $27 | $1,154,464 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $59,356 |
| Goodwill | $0 | $0 | $8,134,068 | $47,807 |
| Intangibles | $2,698 | $2,704 | $556,166 | $423,864 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$8,689,427 | $61,714 |
| Total NC Assets | $2,698 | $2,704 | $807 | $592,741 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,274 | $2,727 | $834 | $1,747,205 |
| Liabilities | – | – | – | – |
| Payables | $5 | $69 | $91 | $151,015 |
| Short-Term Debt | $0 | $44 | $1,055,043 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | -$1,054,945 | $278,763 |
| Total Curr. Liab. | $5 | $113 | $189 | $429,778 |
| LT Debt | $0 | $0 | $0 | $1,008,272 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $202,366 |
| Total NC Liab. | $0 | $0 | $0 | $1,210,638 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $25,785 |
| Total Liabilities | $5 | $113 | $189 | $1,640,416 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3,634 | $2,221 | $990 | $2,397 |
| Retained Earnings | -$480 | -$344 | -$345 | $0 |
| AOCI | $114 | $737 | $0 | $104,392 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $3,268 | $2,614 | $645 | $106,789 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,274 | $2,727 | $8,983,125 | $1,747,205 |
| Net Debt | -$563 | $21 | $1,034,202 | $210,994 |